Total Payments
$10,363
2024 Payments
$130.92
Companies
28
Transactions
94
Medicare Patients
2,756
Medicare Billing
$244,232
Payment Breakdown by Category
Travel$4,968 (47.9%)
Food & Beverage$4,291 (41.4%)
Other$1,105 (10.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $4,968 | 15 | 47.9% |
| Food and Beverage | $4,291 | 78 | 41.4% |
| Grant | $1,105 | 1 | 10.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $5,428 | 22 | $0 (2020) |
| ABIOMED | $1,741 | 4 | $0 (2019) |
| Edwards Lifesciences Corporation | $554.15 | 9 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $554.08 | 12 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $353.85 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.65 | 4 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $232.87 | 6 | $0 (2024) |
| PFIZER INC. | $154.54 | 5 | $0 (2024) |
| Lantheus Medical Imaging, Inc. | $132.39 | 3 | $0 (2017) |
| Abbott Laboratories | $128.63 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.92 | 7 | PFIZER INC. ($35.05) |
| 2023 | $121.97 | 6 | Lexicon Pharmaceuticals, Inc. ($34.91) |
| 2022 | $25.84 | 1 | Medtronic, Inc. ($25.84) |
| 2020 | $2,050 | 16 | Boston Scientific Corporation ($1,127) |
| 2019 | $2,990 | 14 | Boston Scientific Corporation ($2,300) |
| 2018 | $3,974 | 33 | Boston Scientific Corporation ($2,000) |
| 2017 | $1,072 | 17 | ABIOMED ($366.69) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Cardiovascular Device | ||||||
| 04/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Genetic Disease | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Cardiovascular | ||||||
| 04/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Not Applicable | ||||||
| 11/14/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/02/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: Not Applicable | ||||||
| 08/08/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Cardiology | ||||||
| 08/01/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/01/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Cardiovascular | ||||||
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Cardiovascular | ||||||
| 05/21/2022 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Stents | ||||||
| 08/22/2020 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $198.72 | General |
| 08/22/2020 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $18.28 | General |
| 08/21/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $68.00 | General |
| 08/21/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $40.77 | General |
| 08/21/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $34.67 | General |
| 08/21/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $28.00 | General |
| 08/21/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $25.34 | General |
| 08/20/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $103.99 | General |
| 08/20/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $36.38 | General |
| 03/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: DIABETES | ||||||
| 03/03/2020 | Boston Scientific Corporation | GENERAL - STRUCTURAL HEART (Device) | Grant | Cash or cash equivalent | $1,104.99 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,369 | 1,947 | $460,439 | $167,478 |
| 2022 | 16 | 598 | 772 | $176,630 | $60,901 |
| 2021 | 4 | 745 | 879 | $81,121 | $13,200 |
| 2020 | 2 | 44 | 44 | $25,311 | $2,653 |
Total Patients
2,756
Total Services
3,642
Medicare Billing
$244,232
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 346 | $87,386 | $32,633 | 37.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 225 | $45,158 | $20,519 | 45.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $45,280 | $17,099 | 37.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 77 | 82 | $47,511 | $15,712 | 33.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 25 | 38 | $44,012 | $14,391 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 97 | 101 | $39,224 | $13,529 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $27,372 | $9,884 | 36.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 64 | 67 | $26,409 | $9,856 | 37.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 50 | 100 | $22,220 | $7,622 | 34.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 36 | 144 | $17,650 | $6,721 | 38.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 75 | 75 | $10,368 | $3,956 | 38.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 58 | $8,100 | $3,543 | 43.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 189 | 259 | $7,278 | $2,743 | 37.7% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $9,202 | $2,443 | 26.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 50 | 50 | $6,989 | $2,390 | 34.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 19 | 19 | $3,538 | $1,357 | 38.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 101 | 108 | $2,694 | $1,036 | 38.5% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 17 | 18 | $2,555 | $983.34 | 38.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 62 | 67 | $1,824 | $732.31 | 40.2% |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | Office | 2023 | 42 | 42 | $5,670 | $329.28 | 5.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 80 | $31,670 | $12,222 | 38.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 136 | $27,585 | $10,736 | 38.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 17 | 21 | $28,379 | $8,624 | 30.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 42 | 42 | $25,916 | $7,720 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 58 | $12,601 | $5,554 | 44.1% |
About Dr. Muhammad Chaudhry, MD
Dr. Muhammad Chaudhry, MD is a Interventional Cardiology healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1609001262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Chaudhry, MD has received a total of $10,363 in payments from pharmaceutical and medical device companies, with $130.92 received in 2024. These payments were reported across 94 transactions from 28 companies. The most common payment nature is "Travel and Lodging" ($4,968).
As a Medicare-enrolled provider, Chaudhry has provided services to 2,756 Medicare beneficiaries, totaling 3,642 services with total Medicare billing of $244,232. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Interventional Cardiology, Internal Medicine
- Location Mesa, AZ
- Active Since 05/26/2009
- Last Updated 05/28/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1609001262
Products in Payments
- CROSSBOSS (Device) $2,048
- Impella (Device) $1,741
- GENERAL STRUCTURAL HEART (Device) $1,722
- GENERAL - STRUCTURAL HEART (Device) $1,105
- LifeVest (Device) $353.85
- BRILINTA (Drug) $322.93
- ANGIOJET (Device) $254.17
- ELIQUIS (Drug) $250.92
- Definity (Drug) $132.39
- AMPLATZER Occluders (Device) $128.63
- JARDIANCE (Drug) $127.11
- CHANTIX (Drug) $119.49
- GENERAL - STENTS (Device) $115.43
- GENERAL VASCULAR ACCESS (Device) $113.21
- OPSUMIT MACITENTAN (Drug) $111.24
- PRADAXA (Drug) $108.54
- Stellarex (Device) $102.43
- AngioSeal (Device) $96.87
- Interventional Products (Device) $91.61
- XARELTO (Drug) $83.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Mesa
Dr. Nachiket Patel, M.d, M.D
Interventional Cardiology — Payments: $74,214
Interventional Cardiology $74,214
Charles Jost, M.d, M.D
Interventional Cardiology — Payments: $62,027
Interventional Cardiology $62,027
Robert Candipan, Md, MD
Interventional Cardiology — Payments: $31,232
Interventional Cardiology $31,232
I-Hui Chiang, Md, MD
Interventional Cardiology — Payments: $22,867
Interventional Cardiology $22,867
Pridhvi Yelamanchili, Md, MD
Interventional Cardiology — Payments: $17,970
Interventional Cardiology $17,970
Dr. Arpit Sothwal, Md, MD
Interventional Cardiology — Payments: $9,714
Interventional Cardiology $9,714